|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.616 EUR | -1.60% |
|
-8.88% | +11.80% |
| Apr. 11 | Poxel: CDC falls below the 10% threshold | CF |
| Feb. 15 | Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Poxel SA announced that Pierre Legault has been appointed the new chairman of the board of directors. Mr. Legault joined Poxel's board of directors in February 2016 and will succeed Dr. Thierry Hercend, who will continue to support Poxel as a member of its board. Mr. Legault has over 35 years of experience working in the pharmaceutical and biotechnology industry.
He is a member of the board of Tobira Therapeutics (chairman of audit committee), Iroko Pharmaceuticals and NephroGenex.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.80% | 26.35M | |
| +9.58% | 115B | |
| +12.41% | 107B | |
| -12.38% | 22.31B | |
| -3.46% | 21.6B | |
| -3.35% | 18.23B | |
| -38.57% | 17.62B | |
| +7.51% | 14.26B | |
| +35.67% | 12.37B | |
| -24.50% | 8.28B |
POXEL 
